$BBLR
Bubblr Inc. Stock $bblr

$bblr Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000149315224010665 Filed on March 20, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$1.504K	$1.470K	$2.620K
YoY Change
Cost Of Revenue	$622.00
YoY Change
Gross Profit	$882.00		$2.620K
YoY Change
Gross Profit Margin	58.64%		100.0%
Selling, General & Admin	$328.2K	-$238.1K	$2.375M
YoY Change	-0.16%		799.56%
% of Gross Profit	37215.53%		90644.27%
Research & Development	$47.87K		$61.11K
YoY Change	22.25%		-35.44%
% of Gross Profit	5426.87%		2332.29%
Depreciation & Amortization	$2.502K	$20.49K	$12.70K
YoY Change	-19.45%		-11.38%
% of Gross Profit	283.67%		484.58%
Operating Expenses	$438.1K	-$307.7K	$2.921M
YoY Change	116.94%		-32.01%
Operating Profit	-$437.2K		-$2.919M
YoY Change	116.5%		-32.07%
Interest Expense	$3.592K	$97.02K	$13.48K
YoY Change	218.16%		-97.66%
% of Operating Profit
Other Income/Expense, Net	-$23.62K	$71.98K	$268.1K
YoY Change	-54.89%		-308.33%
Pretax Income	-$460.9K	$478.1K	-$2.651M
YoY Change	81.2%		-40.11%
Income Tax		$0.00
% Of Pretax Income		0.0%
Net Earnings	-$460.9K	$478.1K	-$2.651M
YoY Change	81.2%		-40.11%
Net Earnings / Revenue	-30642.75%	32524.49%	-101169.85%
Basic Earnings Per Share	$0.00		-$0.02
Diluted Earnings Per Share	$0.00	$0.00	-$0.02
COMMON SHARES
Basic Shares Outstanding	159.7M shares	157.2M shares	156.7M shares
Diluted Shares Outstanding	159.7M shares		156.7M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$950.00	$7.670K	$7.670K
YoY Change			-76.42%
Cash & Equivalents	$951.00	$7.668K
Short-Term Investments
Other Short-Term Assets	$200.00	$200.00	$200.00
YoY Change			0.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables	$88.94K	$87.50K
Total Short-Term Assets	$89.89K	$95.17K	$95.17K
YoY Change	117.36%	124.37%	124.35%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.349K	$31.30K	$31.30K
YoY Change	-94.87%	-34.73%	-34.74%
Goodwill
YoY Change
Intangibles	$1.410M	$1.457M
YoY Change	4243.23%	4476.85%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.412M	$1.488M	$1.488M
YoY Change	4.45%	8.3%	8.3%
TOTAL ASSETS
Total Short-Term Assets	$89.89K	$95.17K	$95.17K
Total Long-Term Assets	$1.412M	$1.488M	$1.488M
Total Assets	$1.502M	$1.583M	$1.583M
YoY Change	7.8%	11.77%	11.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$398.4K	$373.6K	$373.6K
YoY Change	1.11%	163.84%	163.83%
Accrued Expenses	$1.106M	$943.0K	$878.0K
YoY Change	1048.2%	1782.47%	3040.16%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$264.0K	$170.9K	$170.9K
YoY Change			-57.72%
Total Short-Term Liabilities	$1.768M	$1.487M	$1.487M
YoY Change	55.29%	149.64%	149.63%
LONG-TERM LIABILITIES
Long-Term Debt	$548.3K	$552.6K	$552.6K
YoY Change			3.15%
Other Long-Term Liabilities	$40.37K	$39.12K	$39.12K
YoY Change			-80.29%
Total Long-Term Liabilities	$588.7K	$591.8K	$591.8K
YoY Change	-27.76%	-19.41%	-19.41%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.768M	$1.487M	$1.487M
Total Long-Term Liabilities	$588.7K	$591.8K	$591.8K
Total Liabilities	$2.357M	$2.079M	$2.079M
YoY Change	20.65%	56.32%	56.32%
SHAREHOLDERS EQUITY
Retained Earnings	-$16.10M	-$15.61M
YoY Change	22.38%	21.26%
Common Stock	$1.597M	$1.597M
YoY Change	2.4%	3.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$855.2K	-$496.1K	-$496.1K
YoY Change
Total Liabilities & Shareholders Equity	$1.502M	$1.583M	$1.583M
YoY Change	7.8%	11.77%	11.77%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$460.9K	$478.1K	-$2.651M
YoY Change	81.2%		-40.11%
Depreciation, Depletion And Amortization	$2.502K	$20.49K	$12.70K
YoY Change	-19.45%		-11.38%
Cash From Operating Activities	-$118.2K	$978.5K	$565.9K
YoY Change	-25.39%		-148.38%
INVESTING ACTIVITIES
Capital Expenditures	$15.57K	$226.4K	$248.4K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$16.96K
YoY Change
Cash From Investing Activities	$1.394K	-$226.4K	-$248.4K
YoY Change	-112.52%		4.5%
FINANCING ACTIVITIES
Cash Dividend Paid			$42.88K
YoY Change			114.14%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$92.47K	-685.2K	-$302.2K
YoY Change	-54.48%		-125.25%
NET CHANGE
Cash From Operating Activities	-$118.2K	978.5K	$565.9K
Cash From Investing Activities	$1.394K	-226.4K	-$248.4K
Cash From Financing Activities	$92.47K	-685.2K	-$302.2K
Net Change In Cash	-$6.717K	66.90K	-$24.87K
YoY Change	-360.15%		-18.3%
FREE CASH FLOW
Cash From Operating Activities	-$118.2K	$978.5K	$565.9K
Capital Expenditures	$15.57K	$226.4K	$248.4K
Free Cash Flow	-$133.7K	$752.1K	$317.5K
YoY Change			-127.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001873722
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2022	us-gaap	Gross Profit GrossProfit		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	BBLR	Stock Issued For Payment Of Debt StockIssuedForPaymentOfDebt		usd
CY2022	BBLR	Forfeit Of Deferred Stock Compensation ForfeitOfDeferredStockCompensation		usd
CY2023	BBLR	Share Based Finance Incentive ShareBasedFinanceIncentive		usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse		usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2023	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties		usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2023	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q4	BBLR	Research And Development Other Receivables ResearchAndDevelopmentOtherReceivables		usd
CY2023Q4	BBLR	Repayment Received RepaymentReceived		usd
CY2023Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent		usd
CY2023Q4	BBLR	Assignment Of Receivable AssignmentOfReceivable		usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax		usd
CY2023Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate		usd
CY2022Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate		usd
CY2023	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions		usd
CY2023	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions		usd
CY2022Q4	BBLR	Auditor Fees AuditorFees		usd
CY2022Q4	BBLR	Director Fees DirectorFees		usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent		usd
CY2022Q4	BBLR	Other Accred Liabilities OtherAccredLiabilities		usd
CY2022Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent		usd
CY2023Q4	us-gaap	Convertible Debt ConvertibleDebt		usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable		usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent		usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent		usd
CY2023Q4	BBLR	Conversion Of Stock Amount Converted ConversionOfStockAmountConverted		usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent		usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent		usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber		shares
CY2021Q4	BBLR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2022	BBLR	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2022	BBLR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2023	BBLR	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2023	BBLR	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2023	BBLR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber		shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited		shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares		shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares		shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	14426210	usd
CY2023	dei	Auditor Name AuditorName	BF Borgers CPA PC
CY2023	dei	Auditor Firm AuditorFirmId	5041
CY2023	dei	Auditor Location AuditorLocation	Lakewood, CO
CY2023Q4	us-gaap	Cash Cash	7668	usd
CY2022Q4	us-gaap	Cash Cash	32533	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	87503	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	9884	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	95171	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	42417	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	31302	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	47956	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1456628	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1325995	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1487930	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1373951	usd
CY2023Q4	us-gaap	Assets Assets	1583101	usd
CY2022Q4	us-gaap	Assets Assets	1416368	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	373606	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	141605	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	943007	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	50094	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1487471	usd
CY2023Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Subject To Master Netting Arrangement DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement	39116	usd
CY2022Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Subject To Master Netting Arrangement DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement	198479	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	591755	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	734235	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2079226	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1330091	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	159690447	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	159690447	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	154309318	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	154309318	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	1596904	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13168915	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15612775	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	350830	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-496125	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1583101	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2620	usd
CY2023	us-gaap	Gross Profit GrossProfit	2620	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1859969	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	736775	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	288106	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	2879759	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	514911	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	198455	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	197322	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	387302	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	61106	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	94645	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	2921414	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	4296936	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-2918794	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-4296936	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	71975	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	142212	usd
CY2023	us-gaap	Interest And Other Income InterestAndOtherIncome	104	usd
CY2022	us-gaap	Interest And Other Income InterestAndOtherIncome	1553	usd
CY2023	us-gaap	Interest Expense InterestExpense	13476	usd
CY2022	us-gaap	Interest Expense InterestExpense	575777	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	159363	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	494753	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	50178	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-191454	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	268144	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-128713	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2650650	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4425649	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2650650	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4425649	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-61183	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	34769	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-61183	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	34769	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2711833	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4390880	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	156711520	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	156711520	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	150418280	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	150418280	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1127590	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	75460	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	2044061	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	379814	usd
CY2022	BBLR	Stock Issued During Period Value Issuance Of Common Shares For Debt Conversion StockIssuedDuringPeriodValueIssuanceOfCommonSharesForDebtConversion	28000	usd
CY2022	BBLR	Stock Issued During Period Value Issued Of Common Shares For Waiver StockIssuedDuringPeriodValueIssuedOfCommonSharesForWaiver	71703	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	2353048	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	22133	usd
CY2022	BBLR	Stock Issued During Period Value Issuance Of Preferred Shares StockIssuedDuringPeriodValueIssuanceOfPreferredShares	95768	usd
CY2022	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	60000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	659052	usd
CY2022	BBLR	Stock Issued During Period Value Preferred Shares Dividend StockIssuedDuringPeriodValuePreferredSharesDividend	-64292	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4425649	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	34769	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	86277	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	86277	usd
CY2023	BBLR	Stock Issued During Period Value Issuance Of Common Shares For Investor Relations StockIssuedDuringPeriodValueIssuanceOfCommonSharesForInvestorRelations	285337	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	100000	usd
CY2023	BBLR	Stock Issued During Period Value Issued For Professional Services StockIssuedDuringPeriodValueIssuedForProfessionalServices	65000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	43805	usd
CY2023	BBLR	Stock Issued During Period Value Loan Resolution StockIssuedDuringPeriodValueLoanResolution	821432	usd
CY2023	BBLR	Stock Issued During Period Value Forfeit Restrictive Stock Units StockIssuedDuringPeriodValueForfeitRestrictiveStockUnits	-659052	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	1559597	usd
CY2023	BBLR	Stock Issued During Period Value Preferred Shares Dividend StockIssuedDuringPeriodValuePreferredSharesDividend	-86688	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2650650	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-61183	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-496125	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-496125	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-2650650	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4425649	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	450338	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2119521	usd
CY2023	BBLR	Stock Issued For Payment Of Debt StockIssuedForPaymentOfDebt	821432	usd
CY2023	BBLR	Forfeit Of Deferred Stock Compensation ForfeitOfDeferredStockCompensation	659052	usd
CY2022	BBLR	Share Based Finance Incentive ShareBasedFinanceIncentive	451517	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-90	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	6367	usd
CY2023	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	159363	usd
CY2022	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	494753	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	69714	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	184626	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	372976	usd
CY2023	us-gaap	Depreciation Depreciation	12696	usd
CY2022	us-gaap	Depreciation Depreciation	14326	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	75358	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2637	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	227244	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	8727	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	847917	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	52231	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	565886	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1169701	usd
CY2022	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties	1231	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	248371	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	238897	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-248371	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-237666	usd
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends	42883	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	20026	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	15000	usd
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	10759	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	29943	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	572617	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	520758	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	821162	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	77940	usd
CY2022	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	789000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-302187	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1196849	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-40193	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	180084	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-24865	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-30434	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	32533	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	62967	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	7668	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	32533	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	13039	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	7556	usd
CY2023	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2019-10-22
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2711833	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15612775	usd
CY2023Q4	BBLR	Working Capital WorkingCapital	1375522	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_842_eus-gaap--UseOfEstimates_zdwlvMandlJk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86B_zw4azRoW5oX6">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Not Subject To Master Netting Arrangement DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement	39116	usd
CY2023	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p id="xdx_849_eus-gaap--DerivativesReportingOfDerivativeActivity_zn5Uao7NFKQ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86C_zy6mVAqk7kMh">Common Stock Purchase Warrants and Derivative Financial Instruments</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Common stock purchase warrants and other derivative financial instruments are classified as equity if the contracts (1) require physical settlement or net-share settlement or (2) give the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). Contracts which (1) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (2) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement), or (3) that contain reset provisions that do not qualify for the scope exception are classified as liabilities. The Company assesses the classification of its common stock purchase warrants and other derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5742236	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5742236	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5742236	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5742236	shares
CY2023Q4	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	0.012731	pure
CY2022Q4	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	0.012101	pure
CY2023Q4	us-gaap	Derivative Average Forward Exchange Rate1 DerivativeAverageForwardExchangeRate1	0.012441	pure
CY2022Q4	us-gaap	Derivative Average Forward Exchange Rate1 DerivativeAverageForwardExchangeRate1	0.012430	pure
CY2023	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	50178	usd
CY2022	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	34769	usd
CY2023Q4	us-gaap	Deposit Assets DepositAssets	200	usd
CY2022Q4	us-gaap	Deposit Assets DepositAssets	200	usd
CY2023Q4	BBLR	Research And Development Other Receivables ResearchAndDevelopmentOtherReceivables	80205	usd
CY2023Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	7098	usd
CY2022Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	9684	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	87503	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	9884	usd
CY2022Q4	BBLR	Repayment Received RepaymentReceived	1231	usd
CY2022Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	1891	usd
CY2022Q4	BBLR	Assignment Of Receivable AssignmentOfReceivable	-71540	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-9369	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	85617	usd
CY2023	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	592	usd
CY2023	us-gaap	Property Plant And Equipment Transfers And Changes PropertyPlantAndEquipmentTransfersAndChanges	-6367	usd
CY2023	BBLR	Effects Of Foreign Currency Translation Property Equipment EffectsOfForeignCurrencyTranslationPropertyEquipment	4458	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	83116	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	37661	usd
CY2023	BBLR	Accumulated Depreciation Depletion And Amortization Disposals AccumulatedDepreciationDepletionAndAmortizationDisposals	522	usd
CY2023	us-gaap	Depreciation Depreciation	12696	usd
CY2023	BBLR	Accumulated Depreciation Depletion And Amortization Foreign Currency Translation Adjustments AccumulatedDepreciationDepletionAndAmortizationForeignCurrencyTranslationAdjustments	1959	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	51814	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	31302	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	47956	usd
CY2022	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	0	usd
CY2023	us-gaap	Depreciation Depreciation	12696	usd
CY2022	us-gaap	Depreciation Depreciation	14326	usd
CY2023Q4	BBLR	Finite Lived Trademarks Effects Of Currency Translation FiniteLivedTrademarksEffectsOfCurrencyTranslation	-1804	usd
CY2022Q4	BBLR	Finite Lived Trademarks Effects Of Currency Translation FiniteLivedTrademarksEffectsOfCurrencyTranslation	-3461	usd
CY2023Q4	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	36557	usd
CY2022Q4	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	31826	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3010069	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3010069	usd
CY2023	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	248371	usd
CY2023	us-gaap	Finite Lived Intangible Assets Foreign Currency Translation Gain Loss FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss	154329	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3412769	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3412769	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1684074	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1684074	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	184626	usd
CY2023	BBLR	Finite Lived Intangible Assets Accumulated Amortization Effects Of Currency Translation FiniteLivedIntangibleAssetsAccumulatedAmortizationEffectsOfCurrencyTranslation	87441	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1956141	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1956141	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1456628	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1325995	usd
CY2023	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	248371	usd
CY2022	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	238897	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	184626	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	372976	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	204314	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	204314	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	204314	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	204314	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	204314	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	398500	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1420070	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-836615	usd
CY2023Q4	BBLR	Auditor Fees AuditorFees	42731	usd
CY2023Q4	BBLR	Director Fees DirectorFees	90000	usd
CY2023Q4	BBLR	Dividends Payable DividendsPayable	65016	usd
CY2022Q4	BBLR	Dividends Payable DividendsPayable	22133	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	3143	usd
CY2023Q4	BBLR	Other Accred Liabilities OtherAccredLiabilities	34214	usd
CY2023Q4	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	166986	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	544060	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	24818	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	943007	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	50094	usd
CY2022Q4	us-gaap	Convertible Debt ConvertibleDebt	2287780	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	2287780	usd
CY2022Q4	BBLR	Conversion Of Stock Amount Converted ConversionOfStockAmountConverted	-2287780	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-2558969	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	12324	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	9943	usd
CY2023	BBLR	Remaining Payments Of Financing Costs RemainingPaymentsOfFinancingCosts	12611	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-1928146	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-3589034	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-630823	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-4425649	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	2650650	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	4425649	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.21	pure
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	537383	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	929386	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	256668	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Foreign DeferredTaxAssetsTaxCreditCarryforwardsForeign	594740	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	280715	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	334646	usd
CY2023	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	-53931	usd
CY2022	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	-414168	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.19	pure
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	64292	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	20026	usd
CY2022Q3	BBLR	Loan Payable Related Party Noncurrent LoanPayableRelatedPartyNoncurrent	434060
CY2022Q3	BBLR	Loan Payable Related Party Noncurrent LoanPayableRelatedPartyNoncurrent	525291	usd
CY2023	BBLR	Derivative Loss On Contract DerivativeLossOnContract	28043	usd
CY2023	us-gaap	Gain Loss On Securitization Of Financial Assets GainLossOnSecuritizationOfFinancialAssets	95768	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	3000000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	43805	usd
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	159690447	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	154309318	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	2538101	shares
CY2022	BBLR	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice	0.32
CY2022	BBLR	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y3M7D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	2538101	shares
CY2022Q4	BBLR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	0.32
CY2023	BBLR	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y3M7D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	2538101	shares
CY2023Q4	BBLR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	0.32
CY2023	BBLR	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y3M7D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	2538101	shares
CY2023	BBLR	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm	P3Y3M7D
CY2023Q4	BBLR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	0.32
CY2023Q4	BBLR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber	2538101	shares
CY2023Q4	BBLR	Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice	0.32
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	0.1560
CY2023Q2	BBLR	Option Vest Description OptionVestDescription	Company granted options for purchasing our Common stock to executives, management, and a non-executive director as consideration for time served. The terms of the stock option grants are determined by our Board of Directors and consistent with our 2022 Equity Incentive Plan.
CY2023Q2	BBLR	Option Grant Description OptionGrantDescription	Our stock option grant general policy is that options vest 40% after 90 days of service, and the remaining options vest monthly over two years. The maximum term is ten years.
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	14400000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.1560
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14400000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.1560
CY2023	BBLR	Stock Issued During Period Shares Weighted Average Exercised StockIssuedDuringPeriodSharesWeightedAverageExercised	10032000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.1518
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P9Y3M
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0388	pure
CY2023	BBLR	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Annual Forfeiture ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAnnualForfeiture	0	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.99	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	14400000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.1560
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	10032000	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.1560
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	4368000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	14400000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	10032000	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y3M
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P9Y3M
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.1560
CY2023	BBLR	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Option Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageOptionExercisePrice	0.1618
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue	0.00
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue	0.00
CY2023Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	1559598	usd
CY2023Q4	BBLR	Unrecognized Compensation Liability Current UnrecognizedCompensationLiabilityCurrent	626773	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Description ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription	Company agreed to grant Mr. Morris an option to purchase 3,360,000 shares of common stock at $0.187 per share (628,320), under the 2022 Incentive Plan
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Description ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription	Company agreed to grant Mr. Chetwood an option to purchase 3,360,000 shares of common stock at $0.1625 per share ($546,000), with 40% vesting after 90 days of service and 60% vesting monthly over the following two years

Files In Submission

Name	View Source	Status
0001493152-24-010665-index-headers.html	Edgar Link	pending
0001493152-24-010665-index.html	Edgar Link	pending
0001493152-24-010665.txt	Edgar Link	pending
0001493152-24-010665-xbrl.zip	Edgar Link	pending
bblr-20231231.xsd	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex10-10.htm	Edgar Link	pending
ex10-11.htm	Edgar Link	pending
ex10-12.htm	Edgar Link	pending
bblr-20231231_def.xml	Edgar Link	unprocessable
bblr-20231231_pre.xml	Edgar Link	unprocessable
ex10-13.htm	Edgar Link	pending
ex10-14.htm	Edgar Link	pending
ex10-15.htm	Edgar Link	pending
ex10-16.htm	Edgar Link	pending
ex10-17.htm	Edgar Link	pending
ex10-18.htm	Edgar Link	pending
ex10-19.htm	Edgar Link	pending
ex10-2.htm	Edgar Link	pending
ex10-20.htm	Edgar Link	pending
ex10-3.htm	Edgar Link	pending
ex10-4.htm	Edgar Link	pending
ex10-5.htm	Edgar Link	pending
ex10-6.htm	Edgar Link	pending
ex10-7.htm	Edgar Link	pending
ex10-8.htm	Edgar Link	pending
ex10-9.htm	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex3-1.htm	Edgar Link	pending
ex3-2.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex4-1.htm	Edgar Link	pending
ex4-10.htm	Edgar Link	pending
ex4-11.htm	Edgar Link	pending
ex4-2.htm	Edgar Link	pending
ex4-3.htm	Edgar Link	pending
ex4-4.htm	Edgar Link	pending
ex4-5.htm	Edgar Link	pending
ex4-6.htm	Edgar Link	pending
ex4-7.htm	Edgar Link	pending
ex4-8.htm	Edgar Link	pending
ex4-9.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
form10-k_002.jpg	Edgar Link	pending
form10-k_003.jpg	Edgar Link	pending
form10-k_004.jpg	Edgar Link	pending
form10-k_005.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
form10-k_htm.xml	Edgar Link	completed
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
bblr-20231231_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bblr-20231231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BBLR
Bubblr Inc. Stock $bblr

2024 Q1 Form 10-K Financial Statement

#000149315224010665 Filed on March 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BBLR Bubblr Inc. Stock $bblr

2024 Q1 Form 10-K Financial Statement

#000149315224010665 Filed on March 20, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BBLR
Bubblr Inc. Stock $bblr